+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Organ Transplantation Market (2023-2028) by Type, End-Users, and Geography, Competitive Analysis, Impact of Covid-19, Impact of Economic Slowdown & Impending Recession with Ansoff Analysis

  • PDF Icon


  • 177 Pages
  • January 2023
  • Region: Global
  • Infogence Global Research
  • ID: 5635582

Oral diseases are among the most common noncommunicable diseases worldwide, affecting an estimated 3.5 billion people

The Global Organ Transplantation Market is estimated to be USD 15.9 Bn in 2023 and is expected to reach USD 25.41 Bn by 2028, growing at a CAGR of 9.83%.

Market Dynamics

Market dynamics are forces that impact the prices and behaviors of the stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.

As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.

Market Segmentations

The Global Organ Transplantation Market is segmented based on Type, End-Users, and Geography.
  • By Type, the market is classified into Heart Transplantation, Kidney Transplantation, Liver Transplantation, Lung Transplantation, and Pancreas Transplantation.
  • By End-Users, the market is classified into Hospitals & Care Providers and Transplant Centers
  • By Geography, the market is classified into Americas, Europe, Middle-East & Africa, and Asia-Pacific.

Company Profiles

The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies' recent development and competitive scenario. Some of the companies covered in this report are BioLife Solutions Inc., Bio-Rad Laboratories, CareDx, Inc., CryoLife, Inc., Dr. Franz Köhler Chemie GmbH, Exactech, Illumina Inc., etc.

Countries Studied

  • America (Argentina, Brazil, Canada, Chile, Colombia, Mexico, Peru, United States, Rest of Americas)
  • Europe (Austria, Belgium, Denmark, Finland, France, Germany, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden, Switzerland, United Kingdom, Rest of Europe)
  • Middle-East and Africa (Egypt, Israel, Qatar, Saudi Arabia, South Africa, United Arab Emirates, Rest of MEA)
  • Asia-Pacific (Australia, Bangladesh, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Sri Lanka, Thailand, Taiwan, Rest of Asia-Pacific)

Competitive Quadrant

The report includes a Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis

The report presents a detailed Ansoff matrix analysis for the Global Organ Transplantation Market. Ansoff Matrix, also known as Product/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development, and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.

The analyst analyses the Global Organ Transplantation Market using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.

Based on the SWOT analysis conducted on the industry and industry players, the analyst has devised suitable strategies for market growth.

Why buy this report?

  • The report offers a comprehensive evaluation of the Global Organ Transplantation Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
  • The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
  • The report includes an in-depth market analysis using Porter's 5 forces model, PESTLE Analysis, and the Ansoff Matrix. In addition, the impact of COVID-19 and the impact of economic slowdown & impending recession on the market are also featured in the report.
  • The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
  • The report also contains the competitive analysis using Positioning Quadrants, the analyst's competitive positioning tool.

Report Highlights:

  • A complete analysis of the market, including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market
Frequently Asked Questions about the Global Oral Hygiene Market

What is the estimated value of the Global Oral Hygiene Market?

The Global Oral Hygiene Market was estimated to be valued at $47.31 Billion in 2023.

What is the growth rate of the Global Oral Hygiene Market?

The growth rate of the Global Oral Hygiene Market is 4.0%, with an estimated value of $57.67 Billion by 2028.

What is the forecasted size of the Global Oral Hygiene Market?

The Global Oral Hygiene Market is estimated to be worth $57.67 Billion by 2028.

Who are the key companies in the Global Oral Hygiene Market?

Key companies in the Global Oral Hygiene Market include 21st Century Medicine, AbbVie Inc., Acelity L.P. Inc., Arthrex, Inc., Astellas Pharma Inc., BioLife Solutions Inc., Bio, Rad Laboratories, CareDx, Inc. and CryoLife, Inc..

Table of Contents

1 Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Stakeholders

2 Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Models
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Assumptions of the Study
2.5 Limitations of the Study

3 Executive Summary
3.1 Introduction
3.2 Market Size, Segmentations, and Outlook

4 Market Dynamics
4.1 Drivers
4.1.1 Increase In Number of Organ Transplantation Surgeries
4.1.2 Growing Prevalence of Chronic Diseases and Increasing Cases of Organ Failure
4.1.3 Development of Legalized Channel for Organ Donors and Transplants
4.2 Restraints
4.2.1 Shortage Of Organ Donors And Huge Cost of Treatment
4.3 Opportunities
4.3.1 Technological Advancement in Organ Transplantation Methods
4.3.2 Increase in Awareness of Organ Donation
4.4 Challenges
4.4.1 Social and Ethical Concerns

5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter's Five Forces Analysis
5.3 PESTLE Analysis
5.4 SWOT Analysis
5.5 Impact of COVID-19
5.6 Impact of Economic Slowdown & Impending Recession
5.7 Ansoff Matrix Analysis

6 Global Organ Transplantation Market, By Type
6.1 Introduction
6.2 Heart Transplantation
6.3 Kidney Transplantation
6.4 Liver Transplantation
6.5 Lung Transplantation
6.6 Pancreas Transplantation

7 Global Organ Transplantation Market, By End-Users
7.1 Introduction
7.2 Hospitals & Care Providers
7.3 Transplant Centers

8 Americas' Organ Transplantation Market
8.1 Introduction
8.2 Argentina
8.3 Brazil
8.4 Canada
8.5 Chile
8.6 Colombia
8.7 Mexico
8.8 Peru
8.9 United States
8.10 Rest of Americas

9 Europe's Organ Transplantation Market
9.1 Introduction
9.2 Austria
9.3 Belgium
9.4 Denmark
9.5 Finland
9.6 France
9.7 Germany
9.8 Italy
9.9 Netherlands
9.10 Norway
9.11 Poland
9.12 Russia
9.13 Spain
9.14 Sweden
9.15 Switzerland
9.16 United Kingdom
9.17 Rest of Europe

10 Middle East and Africa's Organ Transplantation Market
10.1 Introduction
10.2 Egypt
10.3 Israel
10.4 Qatar
10.5 Saudi Arabia
10.6 South Africa
10.7 United Arab Emirates
10.8 Rest of MEA

11 APAC's Organ Transplantation Market
11.1 Introduction
11.2 Australia
11.3 Bangladesh
11.4 China
11.5 India
11.6 Indonesia
11.7 Japan
11.8 Malaysia
11.9 Philippines
11.10 Singapore
11.11 South Korea
11.12 Sri Lanka
11.13 Thailand
11.14 Taiwan
11.15 Rest of Asia-Pacific

12 Competitive Landscape
12.1 Competitive Quadrant
12.2 Market Share Analysis
12.3 Strategic Initiatives
12.3.1 M&A and Investments
12.3.2 Partnerships and Collaborations
12.3.3 Product Developments and Improvements

13 Company Profiles
13.1 21st Century Medicine
13.2 AbbVie Inc.
13.3 Acelity L.P. Inc.
13.4 Arthrex, Inc.
13.5 Astellas Pharma Inc.
13.6 BioLife Solutions Inc.
13.7 Bio-Rad Laboratories
13.8 CareDx, Inc.
13.9 CryoLife, Inc.
13.10 Dr. Franz Köhler Chemie GmbH
13.11 Exactech
13.12 Illumina Inc.
13.13 Medtronic PLC
13.14 Novartis Ag
13.15 Organovo Holdings Inc.
13.16 F. Hoffmann-La Roche Ag
13.17 Teva Pharmaceutical Industries Ltd.
13.18 Thermo Fisher Scientific Inc.
13.19 Veloxis Pharmaceutical AS
13.20 XVIVO Perfusion AB

14 Appendix
14.1 Questionnaire

Companies Mentioned

  • 21st Century Medicine
  • AbbVie Inc.
  • Acelity L.P. Inc.
  • Arthrex, Inc.
  • Astellas Pharma Inc.
  • BioLife Solutions Inc.
  • Bio-Rad Laboratories
  • CareDx, Inc.
  • CryoLife, Inc.
  • Dr. Franz Köhler Chemie GmbH
  • Exactech
  • Illumina Inc.
  • Medtronic PLC
  • Novartis Ag
  • Organovo Holdings Inc.
  • F. Hoffmann-La Roche Ag
  • Teva Pharmaceutical Industries Ltd.
  • Thermo Fisher Scientific Inc.
  • Veloxis Pharmaceutical AS
  • XVIVO Perfusion AB